The FDA has declined Alnylam Pharmaceuticals’ request to expand the approval of ...
Bristol Myers Squibb (BMS) is set to make a substantial entry into the field of ...
GSK has established a strategic partnership with Chongqing Zhifei Biological Pro...
Amgen has acquired Ireland-based biotechnology company Horizon Therapeutics in ...
The US is known for having higher list prices for drugs than other high-income ...
The US Food and Drug Administration (FDA) has approved an intravenous (IV) vers...
Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on M...
In recent years, the US has made major strides in the treatment landscape for t...
GSK and Chongqing Zhifei Biological Products (Zhifei) have signed an exclusive ...
Ultimovacs has received an orphan drug designation from the US Food and Drug Ad...
More than 20 companies working alongside the UK’s National Health Service (NHS)...
British biotech AstronauTx has completed a Series A funding round of £48m ($58....
Alnylam Pharmaceuticals has had to abandon its plans to pursue a label expansio...
Venture firm General Catalyst is creating a health-focused business spinout with...
The decision by Bristol Myers Squibb to buy MIrati for $4.8 billion reflects a r...
What's on tap at HLTH, the health care industry jamboree that kicks off this wee...
